Paediatric Endocrinology
International Partner
An Introduction to Paediatric Endocrinology
Paediatric endocrinology is a complex field incorporating many conditions such as over or under activity of the pituitary, thyroid and adrenal glands, type 1 diabetes and metabolic bone disease that affect the paediatric population. Collaboration between a multidisciplinary team of paediatric endocrinology specialists, adult endocrinologists and specialist nurses is important to ensure coordinated and comprehensive care.
Browse our gallery of video highlights and short articles from the conference hub, providing the latest expert insights from major conferences and peer-reviewed articles from the journal portfolio.
Our supporting partners do not constitute an endorsement of the content on this page.
Physician burnout is at a critical point. In this episode, Nicky speaks with Dr Alfred Atanda about why so many physicians are burning out and what can be done to change the trend. From personal experience to system-wide solutions, Dr Atanda shares valuable insights on improving physician well-being and building a more effective healthcare culture.
Presymptomatic autoimmune type 1 diabetes: Strategies for early screening, monitoring and management
Watch expert speakers discuss recent advances in early autoimmune T1D, with insights into screening and evolving monitoring and management strategies.
What if your medical degree could launch more than a clinical career? In this candid and compelling read, Dr Jon Edelson shares his lessons for early-career clinicians ready to think beyond the bedside and explore the business of medicine.
Watch multidisciplinary speakers discuss optimising AID outcomes and individualising AID education to support children with type 1 diabetes.
This year the fields of paediatric and adult endocrinology are coming together in a new collaboration. The European Society for Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE) will co-host their first-ever joint Congress on 10–13 May 2025 at the Bella Centre in Copenhagen, Denmark. This unique event, with the theme ‘Connecting Endocrinology Across the Life Course’, will unite specialists from across the world to foster collaboration, share knowledge and advance clinical care.
The latest clinical evidence surrounding the MiniMed 780G system focuses on expanding its access to younger children with type 1 diabetes. The hope is that by extending its use to children aged 2-6 years, its automated insulin delivery could significantly reduce the burden of diabetes management for families.
Article highlights Lavender and tree tea oils have in vitro oestrogenic and antiandrogenic activity. It has been postulated that these oils may cause prepubertal gynaecomastia and premature thelarche. The association is based on a small number patients (N=12) described in ...
Hypothyroidism usually presents with subtle signs and symptoms. Rarely, longstanding juvenile hypothyroidism can manifest as a syndromic diagnosis of Van Wyk–Grumbach syndrome (VWGS).1 VWGS presents as early menarche, thelarche, galactorrhoea, delayed bone ageing and multi-cystic ovaries, along with long-standing ...
The development of effective therapies for the management of cancer in childhood has led to outstanding improvements in survival over the past decades. With this, a growing population of childhood cancer survivors are subject to long-term sequelae impacting on health. ...
Daily growth hormone (GH) injections can be burdensome for patients and carers. Somapacitan is a long-acting, reversible albumin-binding GH derivative in development for once-weekly administration in patients with growth hormone deficiency (GHD). In this touchENDOCRINOLOGY interview, Prof. Bradley Miller (University ...
The REAL 4 trial is a multicenter, randomized, controlled, double-blind phase 3 study (NCT03811535) to evaluate the efficacy, safety, and tolerability of once-weekly somapacitan vs once-daily growth hormone (GH). In this touchENDOCRINOLOGY interview, Prof. Bradley Miller (University of Minnesota, Minneapolis, MN, USA) ...
Glucagon-like peptide-1 agonists are a class of medications utilized in the treatment of type 2 diabetes and obesity. In this touchENDOCRINOLOGY interview, Prof. Uberto Pagotto (University of Bologna, Bologna, Italy) discusses the impact of glucagon-like peptide 1 agonists on obesity, what other ...
Paediatric obesity is a major threat to health and longevity. Around 7% of children worldwide have early onset severe obesity before the age of 7. In this touchENDOCRINOLOGY interview, Prof. Uberto Pagotto (IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy) discusses the global ...
Log into your Touch Account
Earn and track your CME credits on the go, save articles for later, and follow the latest congress coverage.
Sign up with an Email
Or use a .
This Functionality is for
Members Only
Explore the latest in medical education and stay current in your field. Create a free account to track your learning.
